BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

2142

500271

MFSL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

MAX FINANCIAL SERV LTD performance

Today’s low

Today’s high

₹ 1294.50 ₹ 1314.90
₹ 1305.00

52 week low

52 week high

₹ 864.00 ₹ 1306.45
₹ 1305.00

Open Price

₹ 1304.90

Prev. Close

₹ 1306.80

Volume (Shares)

683613.00

Total traded value

₹ 8921.14

Upper Circuit

₹ 1437.40

Lower Circuit

₹ 1176.20

info

MAX FINANCIAL SERV LTD Share Price Update

As of the latest trading session, MAX FINANCIAL SERV LTD share price is currently at ₹ 1300, which is down by ₹ -6.80 from its previous closing. Today, the stock has fluctuated between ₹ 1294.50 and ₹ 1314.90. Over the past year, MAX FINANCIAL SERV LTD has achieved a return of 33.91 %. In the last month alone, the return has been 14.45 %. Read More...

MAX FINANCIAL SERV LTD fundamentals


  • Market cap (Cr)

    44,671.28

  • P/E Ratio (TTM)

    -4,360.83

  • Beta

    0.67

  • Book Value / share

    195.50

  • Return on equity

    -0.17%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -1.57

info icon alternate text
  • Market cap (Cr)

    44,829.34

  • P/E Ratio (TTM)

    -4,360.83

  • Beta

    0.64

  • Book Value / share

    195.50

  • Return on equity

    -0.17%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -1.57

info icon alternate text

MAX FINANCIAL SERV LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 4.32
Operating Expense 6.22
Net Profit -1.57
Net Profit Margin (%) -36.34
Earnings Per Share (EPS) -0.04
EBITDA -1.18
Effective Tax Rate (%) -5.36
Particulars SEP 2024 (Values in Cr)
Revenue 3.69
Operating Expense 6.27
Net Profit -2.46
Net Profit Margin (%) -66.66
Earnings Per Share (EPS) -0.07
EBITDA -2.17
Effective Tax Rate (%) 1.60
Particulars JUN 2024 (Values in Cr)
Revenue 3.72
Operating Expense 6.12
Net Profit -2.60
Net Profit Margin (%) -69.89
Earnings Per Share (EPS) -0.08
EBITDA -1.98
Effective Tax Rate (%) -12.06
Particulars MAR 2024 (Values in Cr)
Revenue 4.51
Operating Expense 8.75
Net Profit -3.68
Net Profit Margin (%) -81.59
Earnings Per Share (EPS) -0.11
EBITDA -3.60
Effective Tax Rate (%) 6.83
Particulars DEC 2023 (Values in Cr)
Revenue 5.52
Operating Expense 8.18
Net Profit -2.47
Net Profit Margin (%) -44.74
Earnings Per Share (EPS) -0.07
EBITDA -2.30
Effective Tax Rate (%) 6.43
Particulars MAR 2024 (Values in Cr)
Revenue 21.43
Operating Expense 33.39
Net Profit -11.24
Net Profit Margin (%) -52.44
Earnings Per Share (EPS) -0.33
EBITDA -9.86
Effective Tax Rate (%) 2.76
Particulars MAR 2023 (Values in Cr)
Revenue 57.81
Operating Expense 39.10
Net Profit 13.86
Net Profit Margin (%) 23.97
Earnings Per Share (EPS) 0.40
EBITDA 22.44
Effective Tax Rate (%) 27.92
Particulars MAR 2022 (Values in Cr)
Revenue 199.70
Operating Expense 55.12
Net Profit 102.62
Net Profit Margin (%) 51.38
Earnings Per Share (EPS) 2.97
EBITDA 150.70
Effective Tax Rate (%) 30.22
Particulars MAR 2021 (Values in Cr)
Revenue 306.38
Operating Expense 178.56
Net Profit 99.23
Net Profit Margin (%) 32.38
Earnings Per Share (EPS) 3.38
EBITDA 133.49
Effective Tax Rate (%) 23.35
Particulars MAR 2020 (Values in Cr)
Revenue 494.94
Operating Expense 98.90
Net Profit 272.54
Net Profit Margin (%) 55.06
Earnings Per Share (EPS) 10.12
EBITDA 406.40
Effective Tax Rate (%) 31.23
Particulars MAR 2024 (Values in Cr)
Book Value / Share 112.50
ROE % 8.11
ROCE % 8.55
Total Debt to Total Equity 0.14
EBITDA Margin 0.99
Particulars MAR 2023 (Values in Cr)
Book Value / Share 102.39
ROE % 9.24
ROCE % 10.44
Total Debt to Total Equity 0.14
EBITDA Margin 1.81
Particulars MAR 2022 (Values in Cr)
Book Value / Share 114.01
ROE % 6.44
ROCE % 7.94
Total Debt to Total Equity 0.07
EBITDA Margin 1.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share 96.87
ROE % 15.79
ROCE % 16.71
Total Debt to Total Equity 0.00
EBITDA Margin 1.91
Particulars MAR 2020 (Values in Cr)
Book Value / Share 79.65
ROE % 12.98
ROCE % 21.04
Total Debt to Total Equity 0.00
EBITDA Margin 2.49
Particulars MAR 2024 (Values in Cr)
Book Value / Share 195.65
ROE % -0.17
ROCE % -0.17
Total Debt to Total Equity 0.00
EBITDA Margin -45.42
Particulars MAR 2023 (Values in Cr)
Book Value / Share 195.98
ROE % 0.21
ROCE % 0.29
Total Debt to Total Equity 0.00
EBITDA Margin 38.56
Particulars MAR 2022 (Values in Cr)
Book Value / Share 195.58
ROE % 1.53
ROCE % 2.20
Total Debt to Total Equity 0.00
EBITDA Margin 74.59
Particulars MAR 2021 (Values in Cr)
Book Value / Share 192.57
ROE % 2.22
ROCE % 2.90
Total Debt to Total Equity 0.00
EBITDA Margin 43.36
Particulars MAR 2020 (Values in Cr)
Book Value / Share 84.61
ROE % 12.73
ROCE % 18.52
Total Debt to Total Equity 0.00
EBITDA Margin 82.10
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 905.93
Total Assets 162773.46
Total Liabilities 162773.46
Total Equity 4369.54
Share Outstanding 343625221
Price to Book Ratio 5.12
Return on Assets (%) 0.20
Return on Capital (%) 6.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1177.84
Total Assets 131823.78
Total Liabilities 131823.78
Total Equity 3968.49
Share Outstanding 343610151
Price to Book Ratio 3.24
Return on Assets (%) 0.28
Return on Capital (%) 8.43
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 599.55
Total Assets 117748.55
Total Liabilities 117748.55
Total Equity 4484.91
Share Outstanding 345114771
Price to Book Ratio 3.85
Return on Assets (%) 0.21
Return on Capital (%) 5.06
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 508.41
Total Assets 98065.59
Total Liabilities 98065.59
Total Equity 3605.03
Share Outstanding 345090302
Price to Book Ratio 4.46
Return on Assets (%) 0.43
Return on Capital (%) 11.8
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 449.10
Total Assets 74526.21
Total Liabilities 74526.21
Total Equity 2818.85
Share Outstanding 269509487
Price to Book Ratio 4.56
Return on Assets (%) 0.19
Return on Capital (%) 5.14
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 47.79
Total Assets 6769.60
Total Liabilities 6769.60
Total Equity 6752.07
Share Outstanding 345114771
Price to Book Ratio 5.12
Return on Assets (%) -0.16
Return on Capital (%) -0.17
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 57.67
Total Assets 6780.40
Total Liabilities 6780.40
Total Equity 6763.40
Share Outstanding 345114771
Price to Book Ratio 3.24
Return on Assets (%) 0.20
Return on Capital (%) 0.21
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 31.00
Total Assets 6777.01
Total Liabilities 6777.01
Total Equity 6749.59
Share Outstanding 345114771
Price to Book Ratio 3.85
Return on Assets (%) 1.51
Return on Capital (%) 1.52
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.46
Total Assets 6676.55
Total Liabilities 6676.55
Total Equity 6645.46
Share Outstanding 345090302
Price to Book Ratio 4.46
Return on Assets (%) 1.48
Return on Capital (%) 1.49
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.93
Total Assets 2525.55
Total Liabilities 2525.55
Total Equity 2280.32
Share Outstanding 269509487
Price to Book Ratio 4.56
Return on Assets (%) 10.79
Return on Capital (%) 11.95
Particulars MAR 2024 (Values in Cr)
Net Income 414.83
Cash from Operations 6119.97
Cash from Investing -5003.88
Cash from Financing -116.98
Net change in Cash 986.05
Free Cash Flow 6342.86
Particulars MAR 2023 (Values in Cr)
Net Income 527.20
Cash from Operations 10017.40
Cash from Investing -11555.05
Cash from Financing -232.76
Net change in Cash -1865.53
Free Cash Flow 10191.33
Particulars MAR 2022 (Values in Cr)
Net Income 388.65
Cash from Operations 8566.02
Cash from Investing -8835.37
Cash from Financing 387.97
Net change in Cash 48.45
Free Cash Flow 8694.02
Particulars MAR 2021 (Values in Cr)
Net Income 592.89
Cash from Operations 7029.86
Cash from Investing -6851.53
Cash from Financing -92.14
Net change in Cash -51.43
Free Cash Flow 7112.82
Particulars MAR 2020 (Values in Cr)
Net Income 442.48
Cash from Operations 5515.56
Cash from Investing -4990.71
Cash from Financing -382.57
Net change in Cash 78.37
Free Cash Flow 5638.52
Particulars MAR 2024 (Values in Cr)
Net Income -11.55
Cash from Operations -5.75
Cash from Investing 8.57
Cash from Financing -1.14
Net change in Cash -0.21
Free Cash Flow -5.70
Particulars MAR 2023 (Values in Cr)
Net Income 19.24
Cash from Operations -22.63
Cash from Investing 35.85
Cash from Financing -1.76
Net change in Cash 0.01
Free Cash Flow -22.45
Particulars MAR 2022 (Values in Cr)
Net Income 147.08
Cash from Operations 116.99
Cash from Investing -84.66
Cash from Financing -1.07
Net change in Cash 0.16
Free Cash Flow 117.05
Particulars MAR 2021 (Values in Cr)
Net Income 129.46
Cash from Operations 156.78
Cash from Investing 2.40
Cash from Financing -1.72
Net change in Cash -0.06
Free Cash Flow 158.30
Particulars MAR 2020 (Values in Cr)
Net Income 396.33
Cash from Operations 395.36
Cash from Investing -394.55
Cash from Financing 1.11
Net change in Cash -0.14
Free Cash Flow 395.48
Company Name Price P/E P/B Market Cap 52 Week Low/High
ALFRED HERBERT (INDIA) LTD. 2000.00 24.33 1.25 154.00 1125.25 / 2350.00
BAJAJ HOLDINGS & INVS LTD 12325.70 18.26 2.29 137172.72 7667.15 / 13221.50
TATA INVESTMENT CORP LTD 6075.75 98.50 0.98 30740.44 5147.15 / 8075.90
Naperol Investments Limited 1437.10 23.31 0.90 825.90 801.00 / 2041.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
ALFRED HERBERT (INDIA) LTD. 2000.00 24.71 1.40 154.00 1125.25 / 2350.00
ARAVALI SECURITIES & FINANCE L 3.89 0.00 -7.62 5.89 3.44 / 7.89
Bagalkot Udyog Ltd 23.90 0.00 -27.43 20.32 0.00 / 0.00
BAJAJ HOLDINGS & INVS LTD 12325.70 57.02 6.70 137172.72 7667.15 / 13221.50

MAX FINANCIAL SERV LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1305.00 -0.13 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 1273.20
  • 26 Days 1189.10
  • 10 Days 1246.00
  • 50 Days 1150.60
  • 12 Days 1236.70
  • 100 Days 1128.60
  • 20 Days 1206.20
  • 200 Days 1101.20
1300.37 PIVOT

First Support

1289.63

First Resistance

1317.53

Second Support

1272.47

Second Resistance

1328.27

Third Support

1261.73

Third Resistance

1345.43

RSI

80.42

ADX

32.27

MACD

47.62

Williams % R

-1.90

Commodity Channel Index (CCI)

149.79

Date

2025-04-29

Week

577297.00

Same Day

685384.00

Month

726644.00

1 Year

0.68

3 Year

0.78

Over 1 Month

14.45%

down

Over 1 Year

33.91%

down

Over 3 Months

21.69%

down

Over 3 Years

19.92%

down

Over 6 Months

2.68%

down

Over 5 Years

22.53%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

MAX FINANCIAL SERV LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
6.2%
Promoter Holdings
1.74%
FII
44.75%
DII
47.29%
Promoter Shares(Pledge Percentage)
28.67%
Name Shares Category
Mitsui Sumitomo Insurance Company Limited 7.5458088E7 (21.86%) Public Shareholding
Hdfc Mutual Fund - Hdfc Nifty Large Midc Ap 250 Index Fund 3.1123534E7 (9.02%) Public Shareholding
Nippon Life India Trustee Ltd-a/c Nippon India Nifty Midcap 150 Index Fund 2.0561276E7 (5.96%) Public Shareholding
Icici Prudential Nifty Financial Services Ex-bank Etf 2.0351566E7 (5.9%) Public Shareholding
Dsp Multicap Fund 1.3863966E7 (4.02%) Public Shareholding
Kotak Mahindra Trustee Co Ltd A/c Kotak Nifty Midcap 150 Index Fund 9511944.0 (2.76%) Public Shareholding
Aditya Birla Sun Life Trustee P Ltd A/c - Aditya Birla Sun Life Multi Asset Allocation Fund 9501964.0 (2.75%) Public Shareholding
Hdfc Life Insurance Companylimited -shareholders Solvency Margin Account 7976367.0 (2.31%) Public Shareholding
Max Ventures Investment Holdings Private Limited 5595923.0 (1.62%) Shareholding of Promoter and Promoter Group
Mirae Asset Nifty Largemidcap 250 Index Fund 5466387.0 (1.58%) Public Shareholding
Smallcap World Fund, Inc 5464577.0 (1.58%) Public Shareholding
Sbi Life Insurance Co. Ltd 4352333.0 (1.26%) Public Shareholding
Kotak Funds - India Midcap Fund 3700000.0 (1.07%) Public Shareholding
Kuwait Investment Authority Fund F238 3555985.0 (1.03%) Public Shareholding
Polar Capital Funds Plc - Emerging Market Stars Fund 3513654.0 (1.02%) Public Shareholding
Tara Singh Vachani 100000.0 (0.03%) Shareholding of Promoter and Promoter Group
Piya Singh 110333.0 (0.03%) Shareholding of Promoter and Promoter Group
Analjit Singh 110000.0 (0.03%) Shareholding of Promoter and Promoter Group
Neelu Analjit Singh 100000.0 (0.03%) Shareholding of Promoter and Promoter Group
Veer Singh 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

MAX FINANCIAL SERV LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2016 1.8 Final 21 Sep 2016 Equity shares
19 Nov 2015 1.8 Interim 20 Nov 2015 Equity shares
15 Sep 2015 1.0 Final 17 Sep 2015 Equity shares
25 Nov 2014 4.0 Interim 26 Nov 2014 Equity shares
12 Sep 2014 1.8 Final 16 Sep 2014 Equity shares
21 Nov 2013 1.8 Interim 22 Nov 2013 Equity shares
10 Sep 2013 2.2 Final 12 Sep 2013 Equity shares
22 Nov 2012 10.0 Interim 23 Nov 2012 Equity shares
Ex-Date Ex-Bonus Ratio
27 May 2000 08 May 2000 1:1
Ex-Date Old FV NEW FV Record Date
12 Mar 2007 10.0 2.0 19 Mar 2007
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2016 1.8 Final 21 Sep 2016 Equity shares
19 Nov 2015 1.8 Interim 20 Nov 2015 Equity shares
15 Sep 2015 1.0 Final 17 Sep 2015 Equity shares
25 Nov 2014 4.0 Interim 26 Nov 2014 Equity shares
12 Sep 2014 1.8 Final 16 Sep 2014 Equity shares
21 Nov 2013 1.8 Interim 22 Nov 2013 Equity shares
10 Sep 2013 2.2 Final 12 Sep 2013 Equity shares
22 Nov 2012 10.0 Interim 23 Nov 2012 Equity shares
Ex-Date Ex-Bonus Ratio
27 May 2000 08 May 2000 1:1
Ex-Date Old FV NEW FV Record Date
12 Mar 2007 10.0 2.0 19 Mar 2007

MAX FINANCIAL SERV LTD Share Price

Max Financial Services Limited (MFSL), a part of the $4 billion Max Group, is the holding company for Max Life Insurance Company Limited. The Company owns and actively manages an 87% majority stake in Max Life Insurance , India's largest non-bank owned, private life insurance company. The Company is primarily engaged in the business of making and holding investments in its subsidiary, Max Life Insurance Company Limited and providing management advisory services to Group Companies in India.

Max Financial Services (MFS) is the listed holding company for Max Life Insurance Company and was formed soon after the demerger of Max India Limited. In January 2016, the Max Group concluded a mega corporate restructuring wherein the erstwhile Max India was demerged into three separate entities, Max Financial Services (life insurance), Max India (healthcare and allied businesses) and Max Ventures & Industries (manufacturing industries and new entrepreneurial ventures). The original company was renamed Max Financial Services and the ex-demerger stock of MFS started trading from 27 January 2016.

Max Life Insurance is the sole operating subsidiary held by Max Financial Services Limited (MFS). Max Life Insurance is a life insurance joint venture between MFS and Mitsui Sumitomo Insurance (MSI), a Japan headquartered global leader in life insurance. Max Life Insurance offers comprehensive long-term savings, protection and retirement solutions through its high quality agency distribution and multi-channel distribution partners.

Max India Limited (MIL), a multi-business corporate was incorporated in 24th February of the year 1988. In the year 1992, a joint venture company was set up in collaboration with Hutchison Telecom under the name of Hutchison Max Telecom Pvt. Ltd to offer value added telecom services. MIL had entered into memorandum of understanding with Comsat Corporation USA for a joint venture to address the needs of VSAT communication services via satellite. Maxxon India, promoted by MIL, was merged with the company in the year 1993. During the year 1994, an innovative new product for leather industry was introduced under the name of Maxfoil and also in the same year the company commissioned the cellular, paging and VSAT Satellite Communication networks. The joint venture between Max-GB Ltd. and Hindustan Antibiotics Ltd for manufacture of Penicillin G was inaugurated at Pimpri on 8th October of the year 1995. Forays were made into the banking and financial sectors and also into distribution and manufacturing sectors. In March of the year 1996, a joint venture was formed with Atotech BV of the Netherlands for PCB plating and general metal finishing chemicals. A range of Upjohn products manufactured under licence in a new sterile facility were launched. In April of the same year, the unit commissioned at its films metallising plant and launched its metallised BOPP films branded Maxmet'.

Max Corporation, a wholly owned subsidiary of the Company has been amalgamated with the company in the year 1999. MCL stood dissolved without winding up, and all assets and liabilities of MCL were transferred and vested with the Company effective from 14th January of the year 2000. During the year 2000, the company had acquired a majority interest in HealthScribe India Pvt. Ltd. a 100 per cent Indian subsidiary of HealthScribe Inc., one of the World's leading medical transcription companies. MIL sold its 24 per cent stake in the 50:50 penicillin-based bulk pharmaceutical joint venture of Max GB to its foreign partner, the Dutch DSM, for Rs. 26 crores. In the year 2001, Max healthcare, a division of Max India Ltd., has opened two primary (Dr Max) and a secondary (Max Medcentre) healthcare centres in New Delhi. During the identical year of 2001, the company entered into insurance business, Max New York Life the joint venture between Max India and New York Life. Max India became the first private player to shows interest in Health Insurance sector during the year 2002 and also in the year, the company sold its pharmaceutical division to Jubilant Organosys for the consideration of Rs. 62.7 crs.

During 2002-03, the company had entered into the healthcare staffing resources business through a 50% investment in a new Company, Max HealthStaff International Ltd. During the year 2003, Max India closed down the Max Ateev and Alta Cast, the software development and IT enabled business taking a big hit of Rs.65 crs.

During 2004-05, the company divested its equity stake in Comsat Max in favour of Bharti Infotel Ltd, for a cash deal of Rs.33 crores. During 2005, the company decided to amalgamate its wholly owned subsidiaries namely, Max Telecom Ventures Ltd and Max Asia-Pacific Ltd Honkong with the company. In June of the year 2005, the company acquired 19,72,500 equity shares of Max HealthStaff for a consideration of Rs.2.51 Crores, thereby making it a wholly owned subsidiary of the company. Max Super Speciality Hospital (MSSH) was commenced its operations in May of the year 2006.

Neeman Medical International (NMI) had established preferred provider relationship with 5 Pharma major in the year 2006-07. Max Speciality Products (MSP) commissioned a new state-of-the-art-speed BOPP film production line with a capacity of 20000 tonnes per annum in March of the year 2007. The Company to invest Rs 10 billion additionally in Max New York Life, the board decided in September of the year 2007. The Company bagged an Express Healthcare Excellence Awards for the year 2007-08.

On 11 July 2008, Max India Limited and Bupa Group, a leading international health and care company, announced a new partnership to enter the health insurance market in India. The two companies announced the creation of a joint venture called Max Bupa Health Insurance Limited which, subject to regulatory approval, will offer a suite of products to both consumer and business customers. The initial share capital of the JV will be Rs100 crores ( 12million). Bupa Group will take a 26 per cent stake in Max Bupa, the maximum allowed under current Indian rules on foreign investment in the country.

Max India Group crossed $1 billion revenue mark in the financial year ended 31 March 2019.

On 28 December 2009, Max India announced that it had garnered a high value investment of $115 million (about Rs 540 crore) from the private equity arm of global investment bank Goldman Sachs. The investment will be through Fully & Compulsory Convertible Debentures (FCD) carrying a coupon rate of 12% per annum. These FCDs will be converted into equity shares of Max India in 15 months at Rs 216.75 per share. Additionally, the Promoter Group of Max India will be bringing in Rs. 175 crore in the Company. These investments will be used to fund the Company's expanding life insurance, healthcare and health insurance businesses; Max New York Life, Max Healthcare and Max Bupa. Goldman Sachs will have 9.4% stake in Max India after conversion of these FCDs and promoter warrants.

On 12 October 2011, Max India announced that Life Healthcare (LHC), a USD 2 billion South African healthcare major, is set to invest Rs 516.5 crore in Max Healthcare (MHC) for a 26% stake in an all cash transaction. MHC is a subsidiary of Max India.

On 12 April 2012, Max India announced that MS&AD Insurance Group Holdings, a Japan headquartered global insurance powerhouse, will acquire 26% stake in Max New York Life (MNYL), India's 4th largest private life insurance company. In an all cash transaction, MS&AD will pay Rs 2731 crore (US $535 million) for the stake, making it the 2nd largest foreign investment in the Indian Life Insurance sector. Post transaction, Max India's majority stake of 70% will remain unchanged. As a result of this transaction, Max India will get a net cash flow of Rs 802 crore (US $157 million). After this transaction, the company will be rebranded Max Life Insurance Company. The joint relationship with MS will also be highlighted in all the communication.

The Board of Max India Limited on 10 September 2012 approved divestment of its profitable Biaxially Oriented Polypropylene (BOPP) Film division, Max Speciality Films to Treofan, a German global technology leader for BOPP film. Treofan, which develops and sells BOPP films in over 90 countries around the world, has offered an Enterprise Value of Rs 540 crore to acquire 100% stake in Max Speciality Films. The offer from Treofan is subject to financing, a material adverse change clause, confirmatory due diligence, execution of mutually satisfactory sale and purchase agreements, management retention, formal approval from Treofan's Advisory Board and receipt of regulatory and corporate approvals.

On 3 February 2014, Standard Chartered Bank and Max Bupa announced their bancassurance Corporate Agency arrangement to provide Max Bupa's comprehensive health insurance offerings to the diverse customer base of Standard Chartered Bank across the country.

On 10 November 2014, Life Healthcare (LHC), a USD 2 billion South African healthcare major, completed the transaction to equalize its stake Max Healthcare (MHC) by investing Rs 766 crore in Max Healthcare (MHC). LHC has paid Rs 67.5 per share to equalize its stake in MHC in an all cash transaction which puts the enterprise value of MHC at Rs 3650 crore and its Equity value at Rs 2884 crore. IFC, Washington, an existing investor in MHC will also subscribe to additional equity of MHC by infusing Rs 31 crore to maintain their 7.5% stake in an expanded capital base at the same valuation.

On 28 May 2015, Max Healthcare (MHC) announced that it has executed definitive agreements to acquire a controlling stake of 76% in NCR based Pushpanjali Crosslay Hospital (PCH) through a combination of fresh investment and acquisition of shares from existing promoters for the aggregate sum of Rs 287 crore. Situated just 4 kms from Max Super Speciality Hospital in Patparganj, the 340-bedded Pushpanjali Crosslay is at a prime location along the East Delhi-Ghaziabad-Noida corridor. The hospital which has the capacity to expand up to 540 beds is NABH and NABL accredited and has been operational since 2010.

On 28 October 2015, Max Healthcare (MHC) announced a partnership with Smart Group wherein MHC would acquire 51% stake in Saket City Hospital Pvt. Ltd., from Smart Health City Pte Ltd, the Singapore based BK Modi Group company which manages and operates the Delhi based Saket City Hospital (SCH). The transaction is subject to confirmatory diligence, requisite regulatory approvals and other customary conditions. Located in the heart of South Delhi's Saket area, SCH, which started operations in 2013, has 230 operational beds and is currently expanding to 300 beds. Max Healthcare plans to further expand this facility by about 900 additional beds, thereby expanding SCH's capacity to 1,200 beds. This addition represents a more than 50% increase compared to Max Healthcare's current capacity and will significantly enhance access to quality healthcare.

On 23 November 2015, Max Bupa Health Insurance (Max Bupa) announced that its foreign parent Bupa has executed agreements to acquire an additional 23% stake in Max Bupa, one of India's leading standalone health insurers. Bupa will pay around Rs 191 crore to Max India in an all cash transaction, to increase its stake in Max Bupa from 26% to 49%. Bupa was the first foreign insurer to announce its intent to increase its stake to 49% in its Indian health insurance subsidiary after the Government relaxed FDI participation rules for insurance companies.

On 15 January 2016, Max India announced its demerger into three listed companies - Max Financial Services Ltd., Max India Ltd. and Max Ventures & Industries Ltd., to provide its investors with specific and undiluted access to its diverse lines of businesses, unlock shareholder value and enable sharper focus on each operating business. Post restructuring, the erstwhile Max India's existing shareholders will retain one equity share of Rs 2/- in Max Financial Services Limited. They will additionally get one equity share of Rs. 2/- each of the new company Max India Limited for every one equity share held in Max Financial Services and one equity share of Rs. 10/- each of Max Ventures and Industries Limited for every 5 equity shares of Rs. 2/- each held in Max Financial Services.

On 31 July 2017, Max Financial Services (MFS), Max India and Max Life confirmed that the proposed merger with HDFC Standard Life Insurance Company Ltd.(HDFC Life) has been called off. The exclusivity agreement with HDFC Life, valid till 31 July 2017, will not be renewed. The prospective partners had evaluated several alternate structures over the last month. However, the inordinate time associated with finalization and approval of these structures led to this decision. Earlier, the Board of Directors of HDFC Standard Life Insurance Company Ltd.(HDFC Life), Max Life Insurance Company Ltd. (Max Life), Max Financial Services Ltd. (Max Financial Services) and Max India Ltd. (Max India) at their respective meetings held on 8 August 2016 approved entering into definitive agreements for amalgamation of business between the entities through a composite Scheme of Arrangement. It was decided at that time that the life insurance business of Max Financial Services, currently held in Max Life, would demerge into HDFC Life.

In FY2013-14, consequent to certain regulatory changes impacting the distribution of health insurance products by banks, Max Bupa, a health insurance company, took the lead in engaging with several leading banks and signed up corporate agency agreements with four banks viz., Standard Chartered Bank, Federal Bank, RBL Bank and Deutsche Bank. These partners are helping Max Bupa take its products and services to a much wider market.The Board of Max India Limited in its meeting held on January 27, 2015 approved a Corporate Restructuring plan to vertically split the Company through a demerger to three companies, the existing company and the two resulting companies to be listed on demerger becoming effective. This would enable the investors in the Company to have a choice, to be associated with the underlying businesses through separate listed entities, or specifically with the relatively matured business of life insurance, and/or have a separate access to the mature manufacturing business of specialty films, and/or in the health and allied businesses which are in their relative growth phase or nascent stage of development and have higher capital requirements. In addition, the restructuring would also result in a sharper focus on underlying businesses and unlock value for shareholders. The salient details of the Scheme of Demergerare as follows:

i) The existing company, Max India Limited, is proposed to be renamed Max financial Services Limited' upon demerger and will focus solely on the group's flagship life insurance activity, through its 72% shareholding in Max Life Insurance Company Limited, making it the first Indian listed company exclusively focused on life insurance. The Insurance Laws (Amendment) Ordinance, 2014, recently promulgated by the President of India, and widely expected to be approve as an Act, has created renewed investor interest in the life insurance sector.

ii) Upon completion of the demerger, it is proposed to name the second vertical as Max India Limited, (Resulting Company 1), which will continue to manage investments in the high potential health and allied businesses including in: - Max Healthcare Institute Limited, Max Bupa Health Insurance Company Limited, Antara Senior Living Limited and supported by a corporate management services team. The demerger will provide these businesses, which are currently in their growth and development phases, sharpened focus to fulfill their tremendous potential. The corporate management services team will manage shared services facilities and provide functional support to all 3 verticals.

iii) The third vertical will house the investment activity in the group's manufacturing subsidiary, Max Specialty Films Limited - an innovation leader in the speciality packaging films business - and will be named Max Ventures and Industries Ltd (Resulting Company 2).

iv) The Company's shareholders whose name will appear in the register of members on a Record Date', to be specified for the said purpose once the demerger scheme is effective, will retain one equity share of Rs. 2/- in Max financial Services Limited (existing Max India, as renamed). In addition, the shareholders will get shares in the new companies as detailed below: 1) One equity share of Rs. 2/- each of Resulting Company 1 for every one equity share of Rs. 2/- each held in the Company; and 2) one equity share of Rs. 10/- each of Resulting Company 2 for every 5 equity shares of Rs. 2/- each held in the Company. (v) The Company has a Treasury Corpus of Rs. 572 Cr. as at March 31, 2015 It is proposed to split the cash reserves as on Appointed Date of April 1, 2015 between the 3 listed companies such that the Company will hold Rs. 150 Cr., Resulting Company 2 will hold Rs. 10 Cr. and the balance, Rs. 412 Cr., will be held by Resulting Company 1.(vi) The Appointed Date for the demerger is April 1, 2015.

The Company has received approvals from SEBI and CCI for the proposed scheme of demerger. Pursuant to the order of Hon'ble High Court of Punjab and Haryana at Chandigarh, the Court Convened Meeting of shareholders of the Company was held on July 4, 2015 at 11:00 A.M. at the Registered Office of the Company at Bhai Mohan Singh Nagar, Railmajra, Tehsil Balachaur, District Nawanshahr, Punjab - 144 533 and the report of the Court appointed Chairman was filed with the Hon'ble High Court. 99.99% of the total voting of the shareholders of the Company at the meeting and by e voting voted in favour of the Scheme of Demerger. The Company has filed the second petition before the Hon'ble High Court seeking its approval for the Scheme of Demerger.

In May 2015, Max India completed the divestment of Max Neeman, a contract research organization with world-class practices, strong values and deep customer relationships. As a natural owner' of this business, JSS Medical Research, the acquiring firm, will invest in Max Neeman's growth, enabling the Max India Group to focus more on its core businesses.

In FY 2015-16, the company renewed its corporate agency relationship with Axis Bank, with continued access to the strong network of 2,904 branches of Axis Bank in the country. In collaboration with Axis Bank, the company launched 'Maxis 2020' a nationwide transformation of the life insurance selling processes at the bank, used data analytics, including smarter customer targeting, and introduced a digital solution to enable sellers to perform needs- based sales for customers, across a variety of devices such as desktops, tablets and smart phones. The use of technology for life insurance sales rapidly picked up momentum, with over 70% of policies being sold using this new digital solution in the final quarter of the FY 2015-16. This now enables the company to issue a policy in just 4 hours.

The company introduced 3 new products and 4 new Riders in FY 2015-16, covering both Long-Term Savings and Protection. Of the 7 new products and Riders, Max Life Platinum Wealth Plan (PWP) and Max Life Monthly Income Advantage Plan (MIAP), proved to be the most successful in FY 2015-16. In addition to the new product launches, Max Life Guaranteed Income Plan - an existing guaranteed income plan, was re-launched with a unique derivative investment strategy to hedge interest rate risk.

The Board of Directors of Max Financial Services and Max Life Insurance in August 2016 approved the amalgamation of life insurance business of Max Life, with HDFC Life, subject to requisite shareholder and other regulatory approvals, to eventually create the biggest private-sector life insurance company in India. As per the agreed valuation and exchange ratio, the relative valuation of HDFC Life and Max Life would be 69% and 31% respectively. The potential merger, if it fructifies, will create the largest private life insurance company in India. The coming together of two large life insurance companies of India, Max Life Insurance and HDFC Life, is likely to be accretive to its various stakeholders as the two companies enjoys complementary areas of strengths. On the distribution front while Max Life Insurance has long-standing relationships with Axis Bank, Yes Bank and Lakshmi Vilas Bank, HDFC Life has relationships with HDFC Bank, RBL and IDFC Bank, which could create a strong bancassurance growth engine. In addition, the highly productive agency distribution of Max Life Insurance and E-commerce play of both companies is expected to add strength to the multi channel distribution architecture.

During the year under review, the Company acquired 1,41,70,817 equity shares of Rs. 10/- each in Max Life in March 2018. Accordingly, the equity stake of the Company in Max Life increased to 70.75% as at 31 March 2018.

During the FY2019, the Company acquired 1,98,787,368 equity shares of Rs. 10/- each in Max Life. Accordingly, the equity stake of the Company in Max Life increased to 71.79% as at 31 March 2019.

The Board of Directors of the Company in its meeting held on 03 March 2020, had considered and approved the issuance and allotment of up to 7,54,58,088 equity shares of the Company of the face value of Rs. 2 each, fully paid up, on a preferential basis to Mitsui Sumitomo Insurance Company Limited (MSI) for consideration other than cash, i.e. through swap of 39,47,75,831 equity shares of Rs. 10 each of Max Life Insurance Company Limited. In addition, the Company through a call/put option has a right to acquire the remaining shareholding held by MSI at Rs. 85/- for every Equity Share of Rs. 10/- each held by MSI in Max Life ('MSI Put/Call Option'). In this regard, the Company has executed definitive agreements with the parties. The said transaction was subject to receipt of requisite shareholders approvals and regulatory approvals.

On 20 February 2020, the Company and Axis Bank Limited executed a long-term strategic partnership. The Board of Directors of the Company had approved in its meeting held on 27 April 2020 to enter into definitive agreements with Axis Bank for sale of 29% of equity share capital of Max Life, a material subsidiary of the Company, to Axis Bank.

During the year 2019-20,the company acquired 1,41,70,817 equity shares of Rs. 10/- each in Max Life. Accordingly, the equity stake of the Company in Max Life increased to 72.52% as at 31 March 2020.

On 08 December 2020, the Company allotted 7,54,58,088 equity shares of Rs. 2/- each at a price of Rs. 565.11 per equity share amounting to 21.87% of the paid-up share capital of Max Financial Services Limited ('MFSL' or 'Company'), to MSI, on a preferential allotment basis in consideration for the transfer of equity shares constituting 20.57% of the paid up share capital of Max Life held by MSI to MFSL.

Post the Share Swap transaction, MSI holds 21.87% equity shares of the Company and the Company's investment in equity shares of MLIC had increased from 72.52% to 93.10% as of 08 December 2020.

On April 6, 2021, Axis Bank Limited, India's third-largest private sector bank, together with its subsidiaries Axis Capital Limited and Axis Securities Limited became the co-promoters of Max Life after acquiring 12.99% stake collectively by the Axis Entities in Max Life, which had 346 branch units across India as of March 31, 2022.

Max Life's assets under management (AUM) was Rs. 90,407 crore as on March 31, 2021.

During the year 2022, the total new business premium (individual + group) of Max Life increased by 16% to Rs. 7,905 crore. Additionally, the renewal premium income (including Group) grew by 19% to Rs. 14,509 crore, taking the gross written premium to Rs. 22,414 crore.

As of March 31, 2022, the Company had only 1 operating subsidiary vis., Max Life. In addition, Max Life incorporated Max Life Pension Fund Management Limited on February 28, 2022 as its wholly owned subsidiary.

Max Life's assets under management (AUM) were Rs 1,07,510 crore as on March 31, 2022.

As of March 31, 2023, the Company had two operating subsidiaries viz., Max Life Insurance Company Limited and Max Life Pension Fund Management Limited. Further, the Company incorporated one special purpose entity, Max Financial Employees Welfare Trust in April 2022.

Max Life's assets under management (AUM) were Rs 1,22,857 crore as on March 31, 2023.

During the year 2023, the total new business premium (individual + group) of Max Life increased by 13% to Rs. 8,960 crore. Additionally, the renewal premium income (including Group) grew by 13% to Rs. 16,382 crore, taking the gross written premium to Rs. 25,342 crore.

Parent organization Analjit Singh
NSE symbol MFSL
Founded 1988
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Max Financial Services Ltd?

Answer Field

The share price of Max Financial Services Ltd for NSE is ₹ 1300 and for BSE is ₹ 1304.6.

What is the Market Cap of Max Financial Services Ltd?

Answer Field

The market cap of Max Financial Services Ltd for NSE is ₹ 4,46,71.28 Cr. and for BSE is ₹ 4,48,29.34 Cr. as of now.

What is the 52 Week High and Low of Max Financial Services Ltd?

Answer Field

The 52 Week High and Low of Max Financial Services Ltd for NSE is ₹ 1314.90 and ₹ 864.00 and for BSE is ₹ 1314.90 and ₹ 864.30.

How to Buy Max Financial Services Ltd share?

Answer Field

You can trade in Max Financial Services Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Max Financial Services Ltd?

Answer Field

The 1 year returns on the stock has been 33.91%.

What is the Current Share Price of Max Financial Services Ltd?

Answer Field

Max Financial Services Ltd share price is for NSE ₹ 1300 & for BSE ₹ 1304.6 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Max Financial Services Ltd Share?

Answer Field

The market cap of Max Financial Services Ltd for NSE ₹ 4,46,71.28 & for BSE ₹ 4,48,29.34 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Max Financial Services Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Max Financial Services Ltd share is -4360.83.

What is the PB ratio of Max Financial Services Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Max Financial Services Ltd share is 195.50.

How to Buy Max Financial Services Ltd Share?

Answer Field

You can trade in Max Financial Services Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Max Financial Services Ltd Share on Bajaj Broking App?

Answer Field

To buy Max Financial Services Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Max Financial Services Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|